This educational activity is designed for medical oncologists, infectious disease specialists, hematologists, hospitalists, and other physicians, physicians-in-training, and healthcare professionals interested and/or involved in the care of patients with febrile neutropenia.
Objectives Upon completion of this activity, participants should be able to:
- Discuss and evaluate the clinical use of prophylactic versus empiric or preemptive therapy of fungal infections in febrile neutropenic patients
- Discuss the appropriate selection and practical utilization of replacement antibiotics for therapy of infections caused by resistant bacteria in febrile neutropenic patients
- Describe the role of native immunity on susceptibility and severity of infection in patients with febrile neutropenia
- Identify and assess management strategies for infections in patients undergoing stem cell transplant from alternative sources and donors
- Compare current and emerging therapies in the prevention and management of patients with febrile neutropenia
